PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 60 of 812

Advanced search
🇩🇪Researchklinikum.uni-heidelberg.deTier 2 · Direct publisher

Anatomie neu gedacht: Joachim Kirsch geht nach 24 Jahren Forschung und Lehre in den Ruhestand

Universitätsklinikum HeidelbergOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp-1 drugs weight loss retatrutide: Uses, Safety and What to Know

BusinessWorld OnlineOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Nipah virus (NiV): biological principles

Core principles relating to the biology and transmission of Nipah virus.

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Brucella Reference Unit (BRU)

The Brucella Reference Unit (BRU) provides laboratory reference services relating to Brucella specie...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Acute respiratory illness in PPDs and the CYPSE

Managing acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs)...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Understanding the 'Newsweek FDA Weight Loss Drug' Topic: What It Means and How to Verify Updates

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Current FDA Approved Drugs for Weight Loss: Understanding Your Options and How to Verify Them

BusinessWorldOriginal source
🇸🇪CDMOrecipharm.comTier 2 · Direct publisher

Recipharm completes refinancing and secures improved credit ratings

Recipharm PressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

GLP-1 Weight Loss Drug FDA Approval August 2025: What to Expect and Verify

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Restrictions on Bulk Compounding of Popular Weight-Loss Drugs: What This Means for Patients and Providers

BusinessWorld OnlineOriginal source
🇺🇰Researchukri.orgTier 2 · Direct publisher

UK-wide celebration to engage people with research and innovation

Medical Research Council (UKRI)Original source
🇫🇷Industryipsen.comTier 1 · Company source

Driving climate action: Ipsen’s journey toward a lower-carbon car fleet

Ipsen RSSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Mounjaro FDA Approved for Weight Loss? Understanding Its Status and Uses

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Drug Did FDA Take Out of Weight Loss Pills? Understanding the Withdrawal of Fenfluramine

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MDT-BRIDGE Phase 2 Data Signals a Protocol-Driven Model for Adaptive Resectability Assessment in Neoadjuvant NSCLC

The Clinical Trial VanguardOriginal source
🇳🇱Researcheur.nlTier 2 · Direct publisher

Does easy money win elections? Study finds no evidence

Erasmus University RotterdamOriginal source
🇯🇵Industrychugai-pharm.co.jpTier 1 · Company source

2026年12月期第3四半期連結決算

Chugai Pharmaceutical NewsOriginal source
🇯🇵Industrychugai-pharm.co.jpTier 1 · Company source

Chugai Announces 2026 3rd Quarter Results

Chugai PharmaceuticalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Restricting Compounded Versions of Popular Weight Loss Drugs: What This Means for Patients

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran fail

Fierce BiotechOriginal source
🇩🇪Researchklinikum.uni-heidelberg.deTier 2 · Direct publisher

Spielerisch Datensouveränität erleben: MEDILARP erstmals im Einsatz

Universitätsklinikum HeidelbergOriginal source
🌍discoverynews.google.comTier 2 · Trade media

GSK’s B7-H3 ADC drives 67% cancer risk reduction in Hansoh's phase 3 China trial

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab clears two cancer hurdles as its Merus deal faces the real test

MedWatchOriginal source
🌍Industryhealth.ucdavis.eduTier 1 · Company source

UC Davis Health performs first HIV-to-HIV kidney transplant

UC Davis HealthOriginal source
🌍Industryhealth.ucdavis.eduTier 1 · Company source

Extreme risk protection orders are designed to prevent gun violence. But how do they impact the people subject to them?

UC Davis HealthOriginal source
🌍Regulatoryfifarma.orgTier 1 · Regulatory source

A saúde gera retorno: o que a América Latina ganha quando investe em saúde?

FIFARMA NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Weight Loss Drugs Pending FDA Approval: What to Know About Emerging Treatments

BusinessWorld OnlineOriginal source
🌍Regulatoryfifarma.orgTier 1 · Regulatory source

Health Generates Returns: What Does Latin America Gain When It Invests in Health?

FIFARMA NewsOriginal source
🌍Regulatoryfifarma.orgTier 1 · Regulatory source

La salud genera retorno: ¿qué gana América Latina cuando invierte en salud?

FIFARMA NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Understanding the Newest Diet Pill FDA Approved: What You Need to Know

BusinessWorld OnlineOriginal source
🇨🇭Industryroche.comTier 1 · Company source

Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories

Roche NewsroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Understanding the New Medicine for Weight Loss Approved by FDA: What Patients Should Know

www.polskieradio.plOriginal source
🌍Industrynews.intermountainhealth.orgTier 3 · Secondary coverage

Intermountain Health Breaks Ground on a New Era of Children’s Health in Nevada

<![CDATA[Intermountain Health Newsroom]]>Original source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Early Alert: B. Braun Removes Streamline Bloodline Set for Dialog+

The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood l...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Newest Weight Loss Drug Approved: What You Need to Know About Its Use and Considerations

www.polskieradio.plOriginal source
🌍Industrycibeles.com.uyTier 1 · Company source

CATCHER 300

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

SEEDPOWER FS

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

PYRIBAN 48 EC

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

PYRIBAN 48 EC

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

Catcher 300

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uyTier 1 · Company source

Seedpower fs

Cibeles (Uruguay)Original source
🇯🇵Regulatorypmda.go.jpTier 1 · Regulatory source

[IBENTO][IBENTO]Report of PMDA-ATC GMP Inspection Seminar 2026

PMDA JapanOriginal source
🇯🇵Regulatorypmda.go.jpTier 1 · Regulatory source

[ANZEN]PMDA Risk Communications: Tapinarof,etc. posted

PMDA JapanOriginal source
🇯🇵Regulatorypmda.go.jpTier 1 · Regulatory source

[ANZEN]Revisions of PRECAUTIONS: Inclisiran sodium,etc.posted

PMDA JapanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Warns Weight Loss Supplements Hidden Drug Ingredients: What You Need to Know

BusinessWorld OnlineOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

Six-Month Window: DOJ and HHS Launch Healthcare FCA Self-Disclosure Pilot

Hyman, Phelps & McNamara (FDA Law)Original source
🇳🇿Regulatorypharmac.govt.nzTier 1 · Regulatory source

Agenda for November 2026 Pharmacology and Therapeutics advisory committee (PTAC) meeting

Pharmac New ZealandOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approval Today Weight Loss Drug 2026: Understanding the Process and What to Expect

BusinessWorld OnlineOriginal source
🌍Researchuc.clTier 2 · Direct publisher

Cardenal Chomali llama a dignificar la vocación pública en carta a los políticos

PUC ChileOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Chidamide Plus Nivolumab Shows Potential as New Standard of Care in Advanced Melanoma, Reducing Disease Progression Risk by 27% in Global Phase 3 Trial

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Supreme Court preserves broad access to abortion drug mifepristone

ABC News - Breaking News, Latest News and VideosOriginal source
🌍Industrymenicon.comTier 1 · Company source

Menicon’s “1Case Project” Wins the “New Plastic Technology Award”

MeniconOriginal source
🇦🇺Researchnews.flinders.edu.auTier 2 · Direct publisher

Leaving the military about more than finding another job

Flinders University - Health & MedOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDAapproved Weight Loss Drugs 2023: Understanding Their Uses and Safety Considerations

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Phase 3 Trial: New Drug Cuts Endometrial Cancer Death Risk

Bioengineer.orgOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Amgen filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Novartis filed Form 6-K

SEC EDGAROriginal source
🇯🇵Industryotsukakj.jpTier 3 · Secondary coverage

Otsuka Pharmaceutical Factory launches “HINEX E-Gel 1.5,” a concentrated liquid diet with a caloric density of 1.5 kcal/mL designed with intake volume and fluid restriction in mind

Otsuka Holdings RSSOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Government-Owned Inventions; Availability for Licensing

The invention listed below is owned by an agency of the U.S. Government and is available for licensi...

Federal RegisterOriginal source